🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Fostering Data Sharing

Search Papers Authors Institutions Grants FAIR About

TheSindex

Fostering Data Sharing

Empowering the data sharing that empowers science — an open, citation-grounded index for datasets.

Product

Search
API
Explore
Rankings

Resources

Methodology
Data Sources
Documentation
Press

Organization

About
Team
Wikidata

© 2026 theSindex. All rights reserved.

Home
Papers
Structural basis of Chikungunya virus inhibition by monoclonal antibodies

Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Structural basis of Chikungunya virus inhibition by monoclonal antibodies

Proceedings of the National Academy of Sciences(2020)10.1073/pnas.2008051117Source: DataRank Database

Structural basis of Chikungunya virus inhibition by monoclonal antibodies is a research paper published in Proceedings of the National Academy of Sciences (2020). On theSindex it has a DataRank of 0. It has been cited 75 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access75 citations

Cite:

Linked data & code

Additional file 1 of Highly potent multivalent VHH antibodies against Chikungunya isolated from an alpaca naïve phage display library · figshare
Additional file 1 of Highly potent multivalent VHH antibodies against Chikungunya isolated from an alpaca naïve phage display library · figshare
Additional file 2 of Highly potent multivalent VHH antibodies against Chikungunya isolated from an alpaca naïve phage display library · figshare
Additional file 2 of Highly potent multivalent VHH antibodies against Chikungunya isolated from an alpaca naïve phage display library · figshare

pdb

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (11 grants)Impact (FWCI 6.17)OA: greenTopics (77)Linked Datasets (4)DataCite Reuse (4)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (3)

FAIR Checklist

Context only (not used in score)

FFindable (2/2)

Has DOI
Indexed in repositories

AAccessible (1/2)

Open Access

IInteroperable (2/2)

DataCite relations
Linked datasets

RReusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (11)

Julie M. Fox ORCID,James T. Earnest ORCID,Thiam‐Seng Ng ORCID,Arthur S. Kim ORCID,G. Fibriansah ORCID

Live enrichment

PubMed:33087569 PMC:PMC7959576 OpenAlex:https://openalex.org/W3094615536

Ministry of Health -Singapore

Grant: Duke-NUS Signature Research Programme

HHS | National Institutes of Health

Grant: R01 AI141436

HHS | National Institutes of Health

Grant: R01 AI114816

HHS | National Institutes of Health

Grant: R01 AI127513

HHS | National Institutes of Health

Grant: U19 AI142790

HHS | National Institutes of Health

Grant: and contract AI201800001

NIAID NIH HHS

Grant: R01 AI143673

National Institutes of Health

Grant: 5R01AI141436-04

Impairment of B cell Responses by Pathogenic Chikungunya Viruses

National Institutes of Health

Grant: 5R01AI127513-02

IFN Dependent Control of Acute and Chronic Chikungunya Virus Induced Disease

National Institutes of Health

Grant: 5U19AI142790-04

Consortium for Immunotherapeutics against Emerging Viral Threats

National Institutes of Health

Grant: 5R01AI114816-05

Structural and functional basis of ultra potent CHKV neutralization by human mAbs

FWCI

6.17

Citation Percentile

1.0%

Influential Citations

4

Citation Trend

2021

2022

2023

2024

2025

2026

greenLicense: cc-by-nc-nd

repositoryhttps://digitalcommons.wustl.edu/open_access_pubs/9867

GREENhttps://digitalcommons.wustl.edu/open_access_pubs/9867

repositoryhttps://digitalcommons.wustl.edu/open_access_pubs/9867

publisherhttp://www.pnas.org/syndication/doi/10.1073/pnas.2008051117

publisherhttps://pnas.org/doi/pdf/10.1073/pnas.2008051117

Fields of Study

Mosquito-borne diseases and controlViral Infections and VectorsViral Infections and Outbreaks ResearchMedicineBiology0301 basic medicine0303 health sciences03 medical and health sciencesAedesAnimalsAntibodies, MonoclonalAntibodies, NeutralizingAntibodies, ViralBinding SitesChikungunya FeverChikungunya virusChlorocebus aethiopsCryoelectron MicroscopyDisease Models, AnimalHumansImmunoglobulinsMaleMembrane ProteinsMiceVero CellsViral Fusion ProteinsVirus Attachment

MeSH Terms

AedesAnimalsAntibodies, MonoclonalAntibodies, ViralBinding SitesChlorocebus aethiopsChikungunya virusDisease Models, AnimalHumansImmunoglobulinsMaleMembrane ProteinsVero CellsViral Fusion ProteinsCryoelectron MicroscopyMiceVirus AttachmentAntibodies, NeutralizingChikungunya Fever

Keywords

ChikungunyaVirologyMonoclonal antibodyVirusEpitopeAntibodyAlphavirusPathogenBiologyImmunologyChikungunya virusCryo-emMaleBinding SitesCryoelectron MicroscopyAntibodies, MonoclonalImmunoglobulinsMembrane ProteinsVirus AttachmentBiological SciencesAntibodies, ViralAntibodies, NeutralizingDisease Models, AnimalMiceAedesChlorocebus aethiopsAnimalsChikungunya FeverHumansVero CellsViral Fusion Proteins

Sustainable Development Goals

SDG 3: 3. Good healthSDG 14: 14. Life underwaterSDG 0: Good health and well-being

Additional file 1 of Highly potent multivalent VHH antibodies against Chikungunya isolated from an alpaca naïve phage display library

10.6084/m9.figshare.19767944.v1figshare

Additional file 1 of Highly potent multivalent VHH antibodies against Chikungunya isolated from an alpaca naïve phage display library

10.6084/m9.figshare.19767944figshare

Additional file 2 of Highly potent multivalent VHH antibodies against Chikungunya isolated from an alpaca naïve phage display library

10.6084/m9.figshare.19767947.v1figshare

Additional file 2 of Highly potent multivalent VHH antibodies against Chikungunya isolated from an alpaca naïve phage display library

10.6084/m9.figshare.19767947figshare

Related Papers (10)

The continued threat of emerging flaviviruses

N/A

1.0DataRank · unranked

Nature Microbiology(2020)

co-cited

10.1038/s41564-020-0714-0

Zika virus infection enhances future risk of severe dengue disease

Science(2020)

co-cited

10.1126/science.abb6143

Symbiont-mediated cytoplasmic incompatibility: What have we learned in 50 years?

eLife(2020)

co-cited

10.7554/elife.61989

Exploiting insect-specific viruses as a novel strategy to control vector-borne disease

N/A

0.704DataRank · unranked

Current Opinion in Insect Science(2020)

co-cited

10.1016/j.cois.2020.02.005

Broad dengue neutralization in mosquitoes expressing an engineered antibody

PLoS Pathogens(2020)

co-cited

10.1371/journal.ppat.1008103

Antiviral Effectors and Gene Drive Strategies for Mosquito Population Suppression or Replacement to Mitigate Arbovirus Transmission by Aedes aegypti

Insects(2020)

co-cited

10.3390/insects11010052

The vaccinia virus based Sementis Copenhagen Vector vaccine against Zika and chikungunya is immunogenic in non-human primates

npj Vaccines(2020)

co-cited

10.1038/s41541-020-0191-8

Development and optimization of a Zika virus antibody-dependent cell-mediated cytotoxicity (ADCC) assay

Journal of Immunological Methods(2020)

co-cited

10.1016/j.jim.2020.112900

Living in the endosymbiotic world of Wolbachia: A centennial review

Cell Host & Microbe(2021)

co-cited

10.1016/j.chom.2021.03.006

Gene drives gaining speed

Nature Reviews Genetics(2021)

co-cited

10.1038/s41576-021-00386-0